Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
Also received tentative approval for 137 mg
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Subscribe To Our Newsletter & Stay Updated